Overview

24 Hour Ambulatory Cardiac Oxygen Consumption

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
A randomized,double-blind,double-dummy,active controlled,15 week study to evaluate the effects of nebivolol and valsartan alone and in combination on 24-hour ambulatory cardiac work and variability of heart rate-mean central systolic pressure product.
Phase:
Phase 3
Details
Lead Sponsor:
State University of New York at Buffalo
Treatments:
Nebivolol
Valsartan